Skip to content
healthcare.dev

ZIPRASIDONE MESYLATE

NDC 51662-1564, ZIPRASIDONE MESYLATE, injection, powder, lyophilized, for solution, from HF Acquisition Co LLC, DBA HealthFirst.

Product NDC
51662-1564
Status
Listed
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211908
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1564 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZIPRASIDONE MESYLATE20 mg/mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
51662-1564-35166215640310 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c75971f8-9640-a6e8-e053-2995a90af654
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=51662-1564

Use it

Look up 51662-1564 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1564 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51662-1564. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.